Home › Funds › Dauntless Investment Group, LLC › CGTX
Dauntless Investment Group, LLC position in CGTX
COGNITION THERAPEUTICS INC · Health Care
Dauntless Investment Group, LLC reported holding 207,714 shares of CGTX (COGNITION THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$199K, representing 0.20% of its reported portfolio and ranking #37 among its reported holdings. Dauntless Investment Group, LLC has disclosed CGTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Dauntless Investment Group, LLC's CGTX position evolved
Dauntless Investment Group, LLC first disclosed a stake in CGTX in Q4 2025 at 466,000 shares (US$629K). Across 4 filings, Dauntless Investment Group, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 207,714 shares valued at US$199K — a reduction of -163,987 shares quarter over quarter.. Notable position changes include a 44% trim in Q3 2026 (shares fell 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 466.00K | $629.10K | New |
| Q1 2026 | 431.00K | $327.35K | Reduce |
| Q2 2026 | 371.70K | $427.46K | Reduce |
| Q3 2026 | 207.71K | $199.41K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CGTX and 13F data
CGTX (COGNITION THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in CGTX — the largest reported positions include BIOS Capital Management, LP (US$5.76B), Chescapmanager LLC (US$957K), Voss Capital, LP (US$69K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CGTX
- BIOS Capital Management, LP 6.00M sh · $5.76B · Q3 2026
- Chescapmanager LLC 997.03K sh · $957.15K · Q3 2026
- Voss Capital, LP 71.51K sh · $68.65K · Q3 2026
More on Dauntless Investment Group, LLC
FAQ
How long has Dauntless Investment Group, LLC held CGTX?
Dauntless Investment Group, LLC has disclosed CGTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Dauntless Investment Group, LLC's current position in CGTX?
As of Q3 2026, Dauntless Investment Group, LLC holds 207.71K shares of CGTX (COGNITION THERAPEUTICS INC), valued at $199.41K, representing 0.20% of its reported portfolio and ranking #37.
Has Dauntless Investment Group, LLC been buying or selling CGTX?
In the latest 13F filing (Q3 2026), Dauntless Investment Group, LLC reduced its position in CGTX.
Which other funds hold CGTX?
Other major institutional holders of CGTX include BIOS Capital Management, LP, Chescapmanager LLC, Voss Capital, LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.